Among the most significantly downregulated genes in tumor samples were AGBL5, SECISBP2, and PLTP, which are involved in protein deglutamylation, selenoprotein synthesis, and lipid metabolism, respectively, and their downregulation may impact platelet function and stability in cancer [50,51,52]. This evidence concerns the gene SELENOS and cancer.